Welcome to the e-CCO Library!

P139: Inflammatory bowel disease and impairment of working life
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mtir, M.(1)*;Kchir, H.(1);Mechergui, N.(2);Cherif, D.(1);Debbabi, H.(1);Yacoub, H.(1);Hassine, H.(1);Maamouri, N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P139: Significant Changes In Routine Biochemical Markers Occur Up To 5 Years Prior To Inflammatory Bowel Disease Diagnosis: A Case-Control Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Cohen, N.A.(1,2,3);Kliper, E.(4);Zamstein, N.(5);Ziv-Baran, T.(6);Ben Tov, A.(2,3);Kariv, R.(1,2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P140 Factors associated with development of NAFLD in patients with inflammatory bowel disease: a 5-year retrospective study on 225 patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Domislović1, I. Knežević-Štromar1,2, M. Premužić1, M. Brinar1,3, D. Vranešić Bender4, A. Milinković3, M. Matašin3, I. Mikolašević5,6, Ž. Krznarić1,2,4

Created: Thursday, 30 January 2020, 10:12 AM
P140: Biopsies taken from mucosa surrounding dysplastic lesions found during IBD surveillance show a low rate of dysplasia
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Ten Hove*1, E. Mooiweer1, A. Van der Meulen2, E. Dekker3, J. Offerhaus1, C. Ponsioen3, B. Oldenburg1

Created: Friday, 22 February 2019, 9:49 AM
P140: Challenges in colonoscopic surveillance in chronic IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S-L. Gillespie*1, N. Singh-Clark2, A. Shand1, C. Lees1, I. Arnott1, G-T. Ho1, E. Watson1, C. Noble1, S. Din1

Created: Friday, 22 February 2019, 9:41 AM
P140: Costs of home-monitoring by telemedicine versus standard care management of Inflammatory Bowel Disease – a Danish register-based five-year follow-up study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Al-Sheikh, M.(1)*;Olsen, J.(2);Spangaard, M.(2);Egedesø, P.(2);Peters-Lehm, C.(1);Fjordside, E.(1);Bennedsen, M.(1);Burisch, J.(1);Munkholm, P.(1);
Created: Friday, 14 July 2023, 10:48 AM
P140: Immunomodulators are protective against severe COVID 19: results from a large multicentre cohort of inflammatory bowel disease patients
Year: 2022
Source: ECCO'22
Authors: Vuitton, L.(1);Bourrier, A.(2);Uzzan, M.(3);Nachury, M.(4);Amiot, A.(5);Roblin, X.(6);Allez, M.(7);Altwegg, R.(8);Vidon, M.(9);Bourreille, A.(10);Serrero, M.(11);Pelletier, A.L.(12);Filippi, J.(13);Gilletta, C.(14);Simon, M.(15);Laharie, D.(16);Nahon, S.(17);Duveau, N.(18);Biron, A.(19);Viennot, S.(20);Abitbol, V.(21);Elgharabawy, Y.(22);Peyrin-Biroulet, L.(23);
Created: Friday, 11 February 2022, 3:52 PM
P140: Physician attitudes about the use of immunosuppressive therapy for inflammatory bowel disease in the elderly
Year: 2018
Source: ECCO '18 Vienna
Authors:

W.P.W. Chan1,2, S. Kim1, J.N. Ding3, V. Kariyawasam1, R.W. Leong1*

Created: Thursday, 21 February 2019, 9:14 AM
P140: Predicting Non-Responsiveness to Iron Therapy in Anaemic Children with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Bevers , N.(1);Aliu , A.(1);Rezazadeh Ardabili , A.(2);Winkens , B.(3);Raijkmakers , M.(4);van de Vijver , E.(5);Swinkels , D.(6);Pierik , M.(2);van Rheenen , P.(7);
Created: Wednesday, 2 June 2021, 4:12 PM
P140: Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Daffra P.R.*1, Etchevers M.J.1, Sobrero M.J.1, Gonzalez Sueyro R.C.1, Rainero G.2, Carbonnel F.3, Vaysse T.3, Marcolongo M.M.1, De Paula J.A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P141 Scoring endoscopy in pediatric inflammatory bowel disease: a way to improve quality
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Norsa1, A. Ferrari2, S. Arrigo3, M. Bramuzzo4, M. Deganello Saccomani5, G. Di Nardo6, M.T. Illiceto7, E. Miele8, M. Paci9, C. Romano10, E. Romeo11, M. Daperno12, S. oliva13

Created: Thursday, 30 January 2020, 10:12 AM
P141: Characteristics and outcomes of acute colitis presenting via the emergency department in an Irish academic medical centre
Year: 2017
Source: ECCO '17 Barcelona
Authors:

O'Connell J.*1, Keohane S.1, McGreal-Bellone A.1, Naimimohasse S.1, McKiernan S.1, MacCarthy F.1, O'Toole D.1, Meaney J.2, Kevans D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P141: Comparison of diagnostic accuracy of videocapsule endoscopy and CT/MR enterography in patients with established small bowel Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Andrade*, H. Cardoso, R. Gaspar, J. Santos-Antunes, M. Marques, S. Lopes, G. Macedo

Created: Friday, 22 February 2019, 9:49 AM
P141: Factors Associated with Time to Clinical Remission in Pediatric Luminal Crohn’s disease: a Retrospective Cohort Study
Year: 2022
Source: ECCO'22
Authors: Sassine, S.(1,2);Fadela Zekhnine, S.(1,2);Qaddouri, M.(1,2);Djani, L.(1,2);Cambron-Asselin, C.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P141: Faecal calprotectin correlates to UCEIS and can predict short-term recurrence in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Naganuma*1, T. Kobayashi2, T. Kanai1

Created: Friday, 22 February 2019, 9:41 AM
P141: IBUS-SAS for Crohn’s disease ultrasound activity: initial validation and research of the optimal cut-off score
Year: 2021
Source: ECCO'21 Virtual
Authors: Dragoni, G.(1,2,3);Innocenti, T.(1,2);Lynch, E.N.(1,2);Fiorini, C.(1,2);Parisio, L.(1,2);Roselli, J.(1,2);Bagnoli, S.(2);Macrì, G.(2);Rogai, F.(2);Milani, S.(1);Galli, A.(1);Milla, M.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P141: Infliximab therapy for inflammatory pouch pathology: a multi-centre retrospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Segal1*, L. Penez2, S. Mclaughlin3, B. Mullish1, M. Quraishi4, N. Ding5, K. Kandiah6, M. Samaan7, P. Irving7, O. Faiz1,2, S. Clark1,8, A. Hart1,2

Created: Thursday, 21 February 2019, 9:14 AM
P141: Risk Factors of Atherosclerotic Cardiovascular Disease (Ischemic Heart Disease and Cerebrovascular Accident) in Patients With Inflammatory Bowel Disease: a hospital-based cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Muiño, D.(1);Carballo-Folgoso, L.(1)*;Ortega-Carriedo , J.(2);Flórez-Díez, P.(1);de Francisco, R.(1,3);Pérez-Martínez, I.(1,3);Castaño-García, A.(1);Fernández-González, E.(1);García-Pérez, C.(3);Martínez-González, S.(3);Rolle, V.(3);Riestra, S.(1,3);
Created: Friday, 14 July 2023, 10:48 AM
P142 Systematic review: patient perceptions of monitoring tools in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Goodsall1, R. Noy2, T. Nguyen3, S. Costello4, V. Jairath5, R. Bryant4

Created: Thursday, 30 January 2020, 10:12 AM
P142: Danese’s “Red flag Instrument” is ready for clinical practice: the RFi prospective validation
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Roseira1*, H. Tavares de Sousa2, A. Marreiros3, J. Parra4, E. Coelho5, P. Caldeira6, T. Belo6, T. Gago2, A.C. Cunha6, L. Contente2, H. Guerreiro2

Created: Thursday, 21 February 2019, 9:14 AM